Lymphocytic Meningitis with Negative Cryptococcal Antigen and VDRL
Despite negative HSV PCR and VDRL, this patient's CSF profile (85 cells/µL with 61% lymphocytes) is consistent with viral meningitis/encephalitis, and empiric acyclovir should be continued until HSV encephalitis is definitively excluded through repeat testing or alternative diagnosis is confirmed.
Clinical Context and Diagnostic Approach
The CSF findings show:
- Moderate pleocytosis (85 cells/µL) with lymphocytic predominance (61%)
- Negative cryptococcal antigen (effectively excludes cryptococcal meningitis 1, 2)
- Negative VDRL (makes neurosyphilis unlikely, though CSF-VDRL has limited sensitivity of 30-71% 3, 4)
- Presumed negative HSV PCR
Critical Management Decision: When to Stop Acyclovir
Acyclovir can be safely discontinued ONLY if ALL of the following criteria are met 5:
HSV PCR negative on TWO occasions 24-48 hours apart, AND MRI not characteristic for HSV encephalitis
OR
Single negative HSV PCR obtained >72 hours after symptom onset with ALL of the following:
- Unaltered consciousness
- Normal MRI (performed >72 hours after symptom onset)
- CSF <5 white cells/µL
This patient does NOT meet stopping criteria because:
- CSF shows 85 cells/µL (far exceeds the <5 cells/µL threshold)
- Only presumed single negative HSV test mentioned
- Clinical status regarding consciousness and imaging not specified
Why HSV Cannot Be Excluded Yet
Initial HSV PCR can be falsely negative in several scenarios 6, 5:
- Early sampling (<72 hours after symptom onset) - virus may not yet be detectable
- Late sampling - after viral clearance has begun
- Presence of PCR inhibitors (hemoglobin) in CSF
- Neonates/infants have more variable test sensitivity (75-100% vs 96-98% in adults)
The CSF pleocytosis of 85 cells/µL with lymphocytic predominance is entirely consistent with HSV encephalitis, which typically presents with 10-500 WBCs/µL 6.
Recommended Management Algorithm
Immediate Actions:
- Continue IV acyclovir 10 mg/kg every 8 hours (adults with normal renal function) 6, 5
- Repeat lumbar puncture in 24-48 hours for second HSV PCR 5
- Obtain or review MRI brain - look specifically for temporal lobe involvement characteristic of HSV encephalitis 5
If Second HSV PCR is Negative:
- With normal MRI and improving consciousness: Consider stopping acyclovir 5
- With temporal lobe abnormalities OR altered consciousness OR CSF pleocytosis persists: Continue acyclovir and consider third CSF sample at 3-7 days 6, 5
If HSV is Confirmed:
- Continue IV acyclovir for 14-21 days total 5
- Repeat LP at 14-21 days to confirm CSF HSV PCR negativity 5
- If still positive, continue IV acyclovir with weekly PCR until negative 5
Alternative Diagnoses to Consider
Given negative cryptococcal antigen and VDRL, pursue:
Other viral etiologies:
- Varicella zoster virus (VZV) - CSF PCR
- Enteroviruses - CSF PCR
- West Nile virus - CSF IgM (>60% sensitivity) 6
- Epstein-Barr virus - though positive PCR may reflect latent infection 6
Non-infectious causes:
- Autoimmune/paraneoplastic encephalitis
- Drug-induced aseptic meningitis
Neurosyphilis caveat: While CSF-VDRL is highly specific (89-96%), its sensitivity is poor (12-48%) 7. If clinical suspicion remains high (especially with serum RPR ≥1:32 4), consider:
- CSF FTA-ABS (more sensitive)
- CSF CXCL13 (78-83% sensitivity, 76-81% specificity) 7
- Serum treponemal testing if not already done
Common Pitfalls to Avoid
Stopping acyclovir based on single negative HSV PCR when CSF shows significant pleocytosis - this is the most dangerous error given HSV encephalitis mortality without treatment 6, 5
Over-relying on CSF-VDRL to exclude neurosyphilis - sensitivity is only 30-71% 3, 4, 8
Assuming negative cryptococcal antigen is definitive - while highly sensitive, false negatives can occur, particularly early in infection 2
Failing to obtain neuroimaging - temporal lobe involvement strongly suggests HSV even with negative initial PCR 5
The stakes are too high to prematurely discontinue acyclovir - untreated HSV encephalitis carries significant mortality and devastating neurological sequelae, while the risks of continuing empiric acyclovir for several more days are minimal 6, 5.